NASDAQ:IMUX

Immunic Stock Insider Trading

etoro logo Buy IMUX
*Your capital is at risk
$14.17
-0.470 (-3.21%)
At Close: Jun 03, 2026

Immunic Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 42.84M and sold 0 IMUX shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
100.00
Buy 42.84M shares
Sell 0 shares
100% Buy Activity
Negligible or No Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Jun 03, 2025
Buy
Common Stock
P-Purchase
Rudick Richard Alan
Director
Director 143 075
Value: $100.0K
Jun 03, 2025
Buy
Common Stock
P-Purchase
Rudick Richard Alan
Director
Director 143 075
Value: $100.0K
Jun 03, 2025
Buy
Common Stock
P-Purchase
Whaley Glenn
Chief Financial Officer
C-Suite Officer 45 000
Value: $32.1K
May 30, 2025
Buy
Common Stock
A-Award
Whaley Glenn
Chief Financial Officer
C-Suite Officer 25 000
Value: $14.0K
May 30, 2025
Buy
Common Stock
A-Award
Whaley Glenn
Chief Financial Officer
C-Suite Officer 25 000
Value: $14.0K
Dec 04, 2024
Buy
Stock Option
A-Award
Nash Duane
Executive Chairman
CEO / President 300 000
Value: $375.0K
Dec 04, 2024
Buy
Stock Option
A-Award
Muehler Andreas
Chief Medical Officer
Officer 315 000
Value: $393.8K
Dec 04, 2024
Buy
Stock Option
A-Award
Tardio Jason
President And COO
CEO / President 157 500
Value: $196.9K
Dec 04, 2024
Buy
Stock Option
A-Award
Vitt Daniel
CEO And Director
CEO / President 820 000
Value: $1.03M
Dec 04, 2024
Buy
Stock Option
A-Award
Whaley Glenn
Chief Financial Officer
C-Suite Officer 265 000
Value: $331.3K
Dec 04, 2024
Buy
Stock Option
A-Award
Whaley Glenn
Chief Financial Officer
C-Suite Officer 265 000
Value: $331.3K
Dec 04, 2024
Buy
Stock Option
A-Award
Vitt Daniel
CEO And Director
CEO / President 820 000
Value: $1.03M
Dec 04, 2024
Buy
Stock Option
A-Award
Tardio Jason
President And COO
CEO / President 157 500
Value: $196.9K
Dec 04, 2024
Buy
Stock Option
A-Award
Muehler Andreas
Chief Medical Officer
Officer 315 000
Value: $393.8K
Dec 04, 2024
Buy
Stock Option
A-Award
Nash Duane
Executive Chairman
CEO / President 300 000
Value: $375.0K
Nov 12, 2024
Buy
Common Stock
P-Purchase
Rudick Richard Alan
Director
Director 87 300
Value: $100.4K
Nov 12, 2024
Buy
Common Stock
P-Purchase
Rudick Richard Alan
Director
Director 87 300
Value: $100.4K
Jul 22, 2024
Buy
Stock Option
A-Award
Skerjanec Simona
Director
Director 100 000
Value: $146.0K
Jul 22, 2024
Buy
Stock Option
A-Award
Skerjanec Simona
Director
Director 50 000
Value: $73.0K
Jul 22, 2024
Buy
Common Stock
J-Other
Skerjanec Simona
Director 0
Value: $0
Jul 22, 2024
Buy
Common Stock
J-Other
Skerjanec Simona
Director 0
Value: $0
Jul 22, 2024
Buy
Stock Option
A-Award
Skerjanec Simona
Director
Director 50 000
Value: $73.0K
Jul 22, 2024
Buy
Stock Option
A-Award
Skerjanec Simona
Director
Director 100 000
Value: $146.0K
Jul 12, 2024
Buy
Stock Option
A-Award
Tardio Jason
President And COO
CEO / President 500 000
Value: $625.0K
Jul 12, 2024
Buy
Common Stock
J-Other
Tardio Jason
Officer
Officer 0
Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT IMMUNIC INC.
Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and other chronic inflammatory and autoimmune diseases, as well as to treat coronavirus disease. The company i...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE